Hoogwerf, B: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Neuroglycopenic and other symptoms in patients with insulinomas

Ana Marie Dizon, Stephan Kowalyk, Byron J Hoogwerf

Journal:

The American Journal of Medicine

Year:

1999

Language:

english

File:

PDF, 57 KB

english, 1999

52

Association of dyslipidemia and effects of statins on nonmacrovascular diseases

Sarkis B. Baghdasarian, Hani Jneid, Byron J. Hoogwerf

Journal:

Clinical Therapeutics

Year:

2004

Language:

english

File:

PDF, 134 KB

english, 2004

53

Variabilities in blood pressure (BP) control among treated hypertensive patients

Donald G. Vidt, Dennis Sprecher, G.L. Pearce, Byron J. Hoogwerf

Journal:

American Journal of Hypertension

Year:

2002

Language:

english

File:

PDF, 34 KB

english, 2002

54

PO12 Efficacité clinique en pratique courante de l’exénatide comparée à l’insuline glargine chez des patients diabétiques de type 2

M. Pawaskar, Q. Li, B. Hoogwerf, M. Reynolds, C. Cueille, D. Faries, D. Bruhn, R. Bergenstal

Journal:

Diabetes & Metabolism

Year:

2012

Language:

french

File:

PDF, 66 KB

french, 2012

55

P283 Effets de l’exénatide BID sur la fonction rénale et les événements indésirables dans les essais cliniques de phase III

K. Tuttle, C. Brown, C. Bonnard, S. Shenouda, C. Heilmann, B. Hoogwerf, PW. Anderson

Journal:

Diabetes & Metabolism

Year:

2012

Language:

french

File:

PDF, 68 KB

french, 2012

56

Gemfibrozil reduced cardiovascular mortality and morbidity in men with pre-existing CHD

Journal:

Evidence-based Cardiovascular Medicine

Year:

2000

Language:

english

File:

PDF, 69 KB

english, 2000

57

Ramipril reduces the risk of developing diabetes in high-risk people

Byron J. Hoogwerf

Journal:

Evidence-based Cardiovascular Medicine

Year:

2002

Language:

english

File:

PDF, 79 KB

english, 2002

58

Angiographic changes in saphenous vein grafts are predictors of clinical outcomes

Genell L. Knatterud, Carl White, Nancy L. Geller, Lucien Campeau, Sandra A. Forman, Michael Domanski, James S. Forrester, Fredarick L. Gobel, J.Alan Herd, Ann Hickey, Byron J. Hoogwerf, Donald B. Hunn

Journal:

American Heart Journal

Year:

2003

Language:

english

File:

PDF, 114 KB

english, 2003

59

At what level should LDL-cholesterol be reduced for secondary prevention? Rationale and design of the NIH Post-CABG clinical trial

L. Campeau, D.B. Hunninghake, J.A. Herd, G. Knatterud, J.L. Probstfield, S. Yusuf, J.S. Forrester, I. Goldenberg, B. Hoogwerf, C. White, M. Domanski, J. Davignon, NIH Post-CABG Clinical Trial Investig

Journal:

Atherosclerosis

Year:

1994

Language:

english

File:

PDF, 151 KB

english, 1994

60

Associated risk factors do not prevent the beneficial effect of aggressive cholesterol lowering: post CABG trial

L. Campeau, G. Knatterud, D. Hunninghake, M. Domanski, C. White, J. Canner, J. Forrester, N. Geller, F. Gobel, J.A. Herd, B. Hoogwerf, Y. Rosenberg

Journal:

Journal of the American College of Cardiology

Year:

1998

Language:

english

File:

PDF, 121 KB

english, 1998

61

PDB11 RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES TREATED WITH EXENATIDE OR THIAZOLIDINEDIONES: A RETROSPECTIVE ANALYSIS OF THE PHARMETRICS DATABASE

JH Best, E Pelletier, BJ Hoogwerf, WH Herman, MB DeYoung, DB Smith, I Yushmanova, M Hussein

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 77 KB

english, 2010

62

PDB83 TIME TO TREATMENT MODIFICATION AMONG PATIENTS WITH TYPE 2 DIABETES WHO INITIATED EXENATIDE OR INSULIN GLARGINE

M Pawaskar, M Bonafede, BH Johnson, R Fowler, B Hoogwerf

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 80 KB

english, 2010

63

Treatment of type III hyperlipoproteinemia with four different treatment regimens

B.J. Hoogwerf, J.P. Bantle, K. Kuba, I.D. Frantz Jr., D.B. Hunninghake

Journal:

Atherosclerosis

Year:

1984

Language:

english

File:

PDF, 606 KB

english, 1984

64

Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia

Byron J. Hoogwerf, Jeffrey R. Peters, Ivan D. Frantz Jr, Donald B. Hunninghake

Journal:

Year:

1985

Language:

english

File:

PDF, 411 KB

english, 1985

65

Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects

Byron J. Hoogwerf, John P. Bantle, Heidi E. Gaenslen, Beryl Z. Greenberg, Beverly J. Senske, Reynold Francis, Frederick C. Goetz

Journal:

Year:

1986

Language:

english

File:

PDF, 444 KB

english, 1986

66

Lipoprotein abnormalities in patients with lower extremity arteriosclerosis obliterans

Jeffrey W. Olin, Michael D. Cressman, Jess R. Youag, Byron Hoogwerf, Cheryl E. Weinstein

Journal:

Journal of the American College of Cardiology

Year:

1990

File:

PDF, 368 KB

1990

67

920-49 Analysis of the Culprit Lesion and Clinical Events in Post-CABG Patients: Interim Angiographic Results from the Post-CABG Trial

Jozsef Vanyi, Carl W. White, Lucien Campeau, James Forrester, J. Alan Herd, Byron Hoogwerf, Donald Hunninghake, Irvin Goldenberg, Michael Domanski, Genell Knatterud

Journal:

Journal of the American College of Cardiology

Year:

1995

Language:

english

File:

PDF, 150 KB

english, 1995

68

PDB23 THE IMPACT OF TREATMENT MODIFICATION ON HEALTHCARE EXPENDITURE IN PATIENTS WITH TYPE-2 DIABETES INITIATING EXENATIDE BID OR INSULIN GLARGINE

M. Pawaskar, M. Bonafede, B.H. Johnson, R. Fowler, B.J. Hoogwerf

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 57 KB

english, 2011

69

PDB4 MODELING HEALTH AND ECONOMIC OUTCOMES ASSOCIATED WITH EXENATIDE ONCE-WEEKLY VERSUS INSULIN AND PIOGLITAZONE TREATMENT FOR TYPE-2 DIABETES

J.A. Gaebler, G. Soto-Campos, P.E. Alperin, B.J. Hoogwerf, M. Wintle, D. Maggs, J. Han, A. Blickensderfer, R. Pencek, D. Bruhn, B.R. Peskin

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 58 KB

english, 2011

70

The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial

Petar Alaupovic, Jim D. Fesmire, Donald Hunnighake, Michael Domanski, Sandra Forman, Genell L. Knatterud, James Forrester, J.Alan Herd, Byron Hoogwerf, Lucien Campeau, Fredarick L. Gobel

Journal:

Atherosclerosis

Year:

1999

Language:

english

File:

PDF, 106 KB

english, 1999

71

Prognostic factors for atherosclerosis progression in saphenous vein grafts: The postcoronary artery bypass graft (post-CABG) trial

Michael J. Domanski, Craig B. Borkowf, Lucien Campeau, Genell L. Knatterud, Carl White, Byron Hoogwerf, Yves Rosenberg, Nancy L. Geller

Journal:

Journal of the American College of Cardiology

Year:

2000

Language:

english

File:

PDF, 159 KB

english, 2000

72

Fasting blood glucose in the nondiabetic range is a continuous and graded risk factor for CHD

Byron J. Hoogwerf, Dennis L. Sprecher, Gregory L. Pearce, Joseph P. Frolkis, Monica Acevedo, Donald G. Vidt

Journal:

Journal of the American College of Cardiology

Year:

2002

Language:

english

File:

PDF, 146 KB

english, 2002

73

C-reactive protein predicts microalbuminuria

Adrian W. Messerli, Ravish Sachar, Gregory L. Pearce, Byron J. Hoogwerf, Dennis L. Sprecher

Journal:

Journal of the American College of Cardiology

Year:

2002

Language:

english

File:

PDF, 175 KB

english, 2002

74

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk diabetic patients

Eva Lonn, Hertzel Gerstein, Janice Pogue, Qilong Yi, Byron J. Hoogwerf, Jacqueline Bosch, Gilles Dagenais, Salim Yusuf

Journal:

Journal of the American College of Cardiology

Year:

2002

Language:

english

File:

PDF, 185 KB

english, 2002

75

Fluid retention after initiation of thiazolidinedione therapy in diabetic patients with established chronic heart failure

W.H.Wilson Tang, Gary S. Francis, Byron J. Hoogwerf, James B. Young

Journal:

Journal of the American College of Cardiology

Year:

2003

Language:

english

File:

PDF, 118 KB

english, 2003

76

Is the tolerability of long-term thiazolidinedione therapy overstated? Reply

W.H Wilson Tang, Gary S Francis, Byron J Hoogwerf, James B Young

Journal:

Journal of the American College of Cardiology

Year:

2003

Language:

english

File:

PDF, 59 KB

english, 2003

77

1146-108 Association of triglyceride to high-density lipoprotein cholesterol ratio with heart rate recovery in healthy adults

Mehdi H Shishebor, Byron J Hoogwerf, Michael S Lauer

Journal:

Journal of the American College of Cardiology

Year:

2004

Language:

english

File:

PDF, 84 KB

english, 2004

78

833-4 Undertreatment of low serum high-density lipoprotein cholesterol in patients with acute myocardial infarction

Anjli Maroo, W.H.Wilson Tang, Byron Hoogwerf, Stephen G Ellis

Journal:

Journal of the American College of Cardiology

Year:

2004

Language:

english

File:

PDF, 82 KB

english, 2004

79

Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

Dieter Neuser, Alice Benson, Andreas Brückner, Ronald B. Goldberg, Byron J. Hoogwerf, Dr Dieter Petzinna

Journal:

Clinical Drug Investigation

Year:

2005

Language:

english

File:

PDF, 107 KB

english, 2005

80

Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database study

Pawaskar, Manjiri, Bonafede, Machaon, Johnson, Barbara, Fowler, Robert, Lenhart, Gregory, Hoogwerf, Byron

Journal:

BMC Endocrine Disorders

Year:

2013

Language:

english

File:

PDF, 236 KB

english, 2013

81

Hypothyroidism and Moderate Subclinical Hypothyroidism Are Associated with Increased All-Cause Mortality Independent of Coronary Heart Disease Risk Factors: A PreCIS Database Study

McQuade, Christine, Skugor, Mario, Brennan, Danielle M., Hoar, Brian, Stevenson, Cindy, Hoogwerf, Byron J.

Journal:

Year:

2011

Language:

english

File:

PDF, 329 KB

english, 2011

82

Albuminuria y riesgo de eventos cardiovasculares, mortalidad cardiovascular e insuficiencia cardíaca en sujetos diabéticos y no diabéticos

Gerstein, H.C., Mann, J.F.E., Yi, Q., Zinman, B., Dinnen, S.F., Hoogwerf, B.

Journal:

Hipertensión y Riesgo Vascular

Year:

2001

Language:

spanish

File:

PDF, 416 KB

spanish, 2001

83

Intradermal Vaccination

Tuttle, Katherine R., Heilmann, Cory, Hoogwerf, Byron J., Brown, Carl, Anderson, Pamela W.

Journal:

Year:

1983

Language:

english

File:

PDF, 315 KB

english, 1983

84

Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions

Tuttle, Katherine R., Heilmann, Cory, Hoogwerf, Byron J., Brown, Carl, Anderson, Pamela W.

Journal:

General Pharmacology: The Vascular System

Year:

1989

Language:

english

File:

PDF, 81 KB

english, 1989

85

Metastatic squamous cell carcinoma in a sudanese female: challenges of palliative care & ethnogeriatrics

Tuttle, Katherine R., Heilmann, Cory, Hoogwerf, Byron J., Brown, Carl, Anderson, Pamela W.

Journal:

Journal of the American Medical Directors Association

Year:

2007

Language:

english

File:

PDF, 60 KB

english, 2007

86

PDB22 ‘Real-World' Clinical Outcomes of Exenatide Bid Compared to Insulin Glargine in Patients with Type 2 Diabetes

Pawaskar, M., Li, Q., Hoogwerf, B., Reynolds, M.W., Faries, D.E., Bruhn, D., Bergenstal, R.

Journal:

Value in Health

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

87

Delayed progression of atherosclerosis in coronary bypass grafts is similar in women compared to men following aggressive cholesterol lowering despite more frequent risk factors: post CABG trial

Campeau, L., Knatterud, G., Domanski, M., Forrester, J.S., Geller, N., Gobel, F., Herd, J.A., Hoogwerf, B., Hunninghake, D.B., White, C., Rosenberg, Y.

Journal:

Journal of the American College of Cardiology

Year:

1998

Language:

english

File:

PDF, 311 KB

english, 1998

88

8006 Improved outcome after first line chemotherapy in BRCA1- and BRCA2-associated ovarian cancer compared with sporadic ovarian cancer patients

Seynaeve, C., Hoogwerf, D., Kriege, M., Beugelink, S., Jager, A., Collee, J., Berns, E.M., Burg van der, M.E.L., Burger, C.W., Vencken, P.

Journal:

European Journal of Cancer Supplements

Year:

2009

Language:

english

File:

PDF, 48 KB

english, 2009

89

METROPOLITAN LUNACY STATISTICS.

Seynaeve, C., Hoogwerf, D., Kriege, M., Beugelink, S., Jager, A., Collee, J., Berns, E.M., Burg van der, M.E.L., Burger, C.W., Vencken, P.

Journal:

Year:

1906

Language:

english

File:

PDF, 168 KB

english, 1906

90

DRUG SELECTION AND THE MANAGEMENT OF CORTICOSTEROID-RELATED DIABETES MELLITUS

Hoogwerf, Byron, Danese, Rossana D.

Journal:

Rheumatic Disease Clinics of North America

Year:

1999

Language:

english

File:

PDF, 1001 KB

english, 1999

91

Surgical endocrinology: Clinical syndromes, 2nd edition

Hoogwerf, Byron J.

Journal:

Trends in Endocrinology & Metabolism

Year:

1992

Language:

english

File:

PDF, 316 KB

english, 1992

92

POSTOPERATIVE MANAGEMENT OF THE DIABETIC PATIENT

Hoogwerf, Byron J.

Journal:

Medical Clinics of North America

Year:

2001

Language:

english

File:

PDF, 1000 KB

english, 2001

93

Chronic inflammation adds to metabolic syndrome in the prediction of microalbuminuria

Messerli, Adrian W., Pearce, Gregory L., Hoogwerf, Byron, Sprecher, Dennis L.

Journal:

Journal of the American College of Cardiology

Year:

2003

Language:

english

File:

PDF, 189 KB

english, 2003

94

Mean Sojourn Time of Packets in a Computer Communications Network

Journal:

Advances in Applied Probability

Year:

1978

Language:

english

File:

PDF, 245 KB

english, 1978

95

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

Denise E Bonds, Michael E Miller, Richard M Bergenstal, John B Buse, Robert P Byington, Jeff A Cutler, Rjames Dudl, Faramarz Ismail-Beigi, Angela R Kimel, Byron Hoogwerf, Karen R Horowitz, Peter J Sav

Journal:

Year:

2010

Language:

english

File:

PDF, 352 KB

english, 2010

96

A Double-Blind Placebo-Controlled Trial Evaluating the Safety and Efficacy of Acarbose for the Treatment of Patients With Insulin-Requiring Type II Diabetes

Coniff, R. F., Shapiro, J. A., Seaton, T. B., Hoogwerf, B. J., Hunt, J. A.

Journal:

Year:

1995

Language:

english

File:

PDF, 571 KB

english, 1995

97

Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications

Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., Purnell, J. Q., Wheeler, M.

Journal:

Year:

2002

Language:

english

File:

PDF, 432 KB

english, 2002

98

Phencyclidine-Induced Rhabdomyolysis and Acute Renal Failure

Hoogwerf, Byron, Kern, James, Bullock, Milton, Comty, Christina M.

Journal:

Clinical Toxicology (Informa Healthcare)

Year:

1979

Language:

english

File:

PDF, 368 KB

english, 1979

99

Advances in the Treatment of Diabetes Mellitus in the Elderly

Byron J. Hoogwerf,Adi Mehta,Sethu Reddy

Journal:

Year:

1996

Language:

english

File:

PDF, 1.21 MB

english, 1996

100

Gender Differences in Utilization of Effective Cardiovascular Secondary Prevention: A Cleveland Clinic Prevention Database Study

Cho, Leslie, Hoogwerf, Byron, Huang, Julie, Brennan, Danielle M., Hazen, Stanley L.

Journal:

Journal of Women's Health

Year:

2008

Language:

english

File:

PDF, 131 KB

english, 2008